Lv1
30 积分 2022-10-09 加入
Dual GIP and GLP-1 receptor agonist tirzepatide alleviates hepatic steatosis and modulates gut microbiota and bile acid metabolism in diabetic mice
2天前
已完结
Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age
11天前
已完结
Effect of tirzepatide on blood pressure and lipids: A meta‐analysis of randomized controlled trials
15天前
已完结
Diagnosis and Management of Hyponatremia
1个月前
已完结
Sleep Immune Cross Talk and Insomnia
2个月前
已完结
Obstructive sleep apnoea heterogeneity and cardiovascular disease
2个月前
已完结
Highlights of mechanisms and treatment of obesity-related hypertension
7个月前
已完结
Lack of pain during myocardial infarction in diabetics —Is autonomic dysfunction responsible?
2年前
已完结
Cardiovascular, renal, and lower limb outcomes in patients with type 2 diabetes after percutaneous coronary intervention and treated with sodium–glucose cotransporter 2 inhibitors vs. dipeptidyl peptidase-4 inhibitors
2年前
已完结
Cardiovascular, renal, and lower limb outcomes in patients with type 2 diabetes after percutaneous coronary intervention and treated with sodium–glucose cotransporter 2 inhibitors vs. dipeptidyl peptidase-4 inhibitors
2年前
已完结
皖公网安备34019202002308
